Investec Bank plc has filed a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group plc (AMS.L) on 3rd August 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc is identified in the filing as both Advisor and Joint Broker to Advanced Medical Solutions Group plc, establishing its connected status to the offer.
The filing was submitted in a client-serving capacity, as required under the exemptions framework set out by the Takeover Panel.
According to the disclosure, Investec purchased a total of 90,530 ordinary shares in Advanced Medical Solutions Group plc during the dealing date.
The purchases were transacted at prices ranging from a low of 279.75 pence per unit to a high of 280.26 pence per unit.
In addition to purchases, Investec also recorded sales of 90,530 ordinary shares, with prices ranging from 279.75 pence to 280.75 pence per unit.
No cash-settled derivative transactions, stock-settled derivative transactions, or other dealings such as subscriptions or conversions were reported in the filing.
The disclosure confirms there are no indemnity arrangements, options, or other agreements that could constitute an inducement to deal or refrain from dealing in the relevant securities.
Investec also confirmed no agreements or understandings exist relating to voting rights or future acquisition and disposal of any securities referenced by derivatives.
The contact named in the filing is Abhishek Gawde, reachable by telephone, with the disclosure formally dated 4th August 2026.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service for transparency and market oversight purposes.
